{
    "nctId": "NCT01286168",
    "briefTitle": "Trial of Drain Antisepsis After Tissue Expander Breast Reconstruction",
    "officialTitle": "Trial of Drain Antisepsis After Tissue Expander Breast Reconstruction",
    "overallStatus": "COMPLETED",
    "conditions": "Nonmalignant Breast Conditions, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 110,
    "primaryOutcomeMeasure": "Number of Subjects With Drain Bulb Fluid Bacterial Colonization at Approximately 1 Week",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Females or males age 18-90 able to give informed consent\n* Undergoing bilateral mastectomy with immediate expander reconstruction or immediate implant reconstruction\n* May have either malignant or benign breast condition\n\nExclusion Criteria:\n\n* Antibiotic use in the fourteen days prior to surgical date\n* Undergoing unilateral tissue expander reconstruction\n* Documented allergy to chlorhexidine gluconate\n* Prior radiation therapy to the breast or chest wall (ie for breast conservation or mantle radiation for Hodgkin's disease)\n* Documented allergy to all three of the following antibiotics: cephalosporin, trimethoprim/sulfamethoxazole, and levofloxacin\n* Pregnant women\n* Vulnerable subjects - prisoners, institutionalized individuals\n* Non-English speaking patients without adequate interpreter assistance",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}